Alessandra Ottani
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Multiparametric Bioresorbable Sensor for Doxorubicin Detection via Molecularly Imprinted Synthetic Receptors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 26, 2025
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo.
Journal: Journal of clinical medicine
Published: December 16, 2024
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.
Journal: Biochemical pharmacology
Published: September 09, 2023
Corrigendum to "Modulation of the JAK/ERK/STAT signaling in melanocortin -induced inhibition of local and systemic responses to myocardial ischemia/reperfusion [Pharmacological Research 72 (2013) 1-8].
Journal: Pharmacological research
Published: July 16, 2023
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice.
Journal: Frontiers in immunology
Published: October 27, 2022
Oxidative Stress in Alzheimer's Disease: In Vitro Therapeutic Effect of Amniotic Fluid Stem Cells Extracellular Vesicles.
Journal: Oxidative medicine and cellular longevity
Published: May 27, 2020
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.
Journal: Molecular neurobiology
Published: March 06, 2017
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: October 04, 2016
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives.
Journal: Progress in neurobiology
Published: May 20, 2015
NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.
Journal: European journal of pharmacology
Published: May 11, 2015
Last Updated: 09/26/2026